Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-01-05

Clinical Trial Update: To Determine the Minimum Amount of Alternaria Alternata Allergen Extract Producing a Positive Skin Reaction. [Phase 2]

View source ↗

Summary

Phase 2 trial completed to determine the minimum dose of Alternaria alternata allergen extract that yields a positive skin reaction in individuals with allergy …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alternaria alternata allergen extract (Alternaria alternata allergen extract)

Snippet

Sponsor: Laboratorios Leti, S.L. | Conditions: Allergy to Alternaria Fungus | Phase 2 | Status: COMPLETED